Response to Comments: MolDX: Pigmented Lesion Assay

This document is a response-to-comments notice regarding the MolDX: Pigmented Lesion Assay Local Coverage Determination (L38051/DL38051). It provides administrative timing: comment period 05/06/2019–06/20/2019, notice period beginning 12/26/2019, and an effective date of 02/10/2020; it does not itself define clinical coverage criteria.

"Administrative details: comment period for MolDX: Pigmented Lesion Assay LCD (DL38051/L38051) ran 2019-05-06 to 2019-06-20; notice period begins 2019-12-26; LCD becomes effective 2020-02-10."

Sign up to see full coverage criteria, indications, and limitations.